Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles
Year: 2010
Type: article
Source: Virology
Institutions: Rega Institute for Medical Research, KU Leuven
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Gilead Sciences
OpenAlex ID: W1967390610
